IVF Add-Ons – Do PGT-A, ERA, and Immune Testing Improve Success?

In vitro fertilization (IVF) has helped millions of people build their families. Alongside standard IVF treatment, many fertility clinics offer additional procedures known as IVF add-ons. These optional tests and treatments are designed to improve the chances of a successful pregnancy in selected situations, but not every add-on has strong scientific evidence supporting routine use.

Three of the most commonly discussed IVF add-ons are Preimplantation Genetic Testing for Aneuploidy (PGT-A), the Endometrial Receptivity Analysis (ERA), and immune testing. Understanding what these options involve can help you make informed decisions with your fertility specialist.

What Are IVF Add-Ons?

IVF add-ons are optional procedures or tests that may be offered before, during, or after an IVF cycle. They are intended to address specific concerns such as embryo selection, implantation, or possible immune-related issues.

While some patients may benefit from certain add-ons, others may not experience any improvement in pregnancy outcomes. The best choice depends on your medical history, age, fertility diagnosis, and previous IVF experiences.

PGT-A (Preimplantation Genetic Testing for Aneuploidy)

PGT-A is a laboratory test performed on embryos created during IVF. A few cells are removed from the embryo and analyzed to determine whether it has the correct number of chromosomes.

Potential Benefits

• May help identify embryos with normal chromosome numbers
• Can reduce the chance of transferring embryos with chromosomal abnormalities
• May lower the risk of miscarriage in selected patients
• Can assist in embryo selection when multiple embryos are available

Who May Benefit?

PGT-A may be considered for:

• Women of advanced maternal age
• Patients with recurrent pregnancy loss
• Couples with repeated IVF failures
• Individuals producing multiple embryos during IVF

Limitations

PGT-A cannot guarantee pregnancy or the birth of a healthy baby. Some embryos may also show mosaic results, making interpretation more complex.

ERA (Endometrial Receptivity Analysis)

ERA is a test designed to determine whether the lining of the uterus is ready for embryo implantation.

The test involves taking a small biopsy of the uterine lining during a mock treatment cycle. The laboratory analyzes gene expression to identify the most receptive implantation window.

Possible Advantages

• May identify a displaced implantation window
• Could help personalize embryo transfer timing
• Sometimes recommended after repeated implantation failure

Current Evidence

Recent studies suggest that ERA may not improve pregnancy rates for most IVF patients. It is generally reserved for selected clinical situations rather than routine use.

Immune Testing in IVF

Some clinics recommend immune testing to investigate whether immune system activity may affect embryo implantation.

Common tests may include:

• Natural Killer (NK) cell testing
• Autoimmune antibody screening
• Antiphospholipid antibody testing
• Thyroid antibody evaluation
• Inflammatory marker assessments

Possible Treatments

Depending on results, treatments may include:

• Low-dose aspirin
• Heparin
• Steroids
• Intravenous immunoglobulin (IVIG)
• Intralipid infusions

What Does the Evidence Say?

Most professional fertility organizations state that routine immune testing and immune therapies have limited scientific evidence for improving IVF success in patients without diagnosed immune disorders.

Benefits of IVF Add-Ons

Some IVF add-ons may provide benefits in carefully selected cases, including:

• Personalized treatment planning
• Better embryo selection
• Reduced miscarriage risk in specific patients
• Improved understanding of fertility challenges
• Additional information for clinical decision-making

Possible Risks and Considerations

Before choosing any IVF add-on, consider:

• Additional costs
• Limited evidence for some procedures
• Emotional expectations
• Extra appointments and testing
• Potential treatment delays

Ask your fertility specialist whether an add-on is supported by current research for your specific situation.

Questions to Ask Your Fertility Specialist

Before proceeding with any IVF add-on, consider asking:

• Why do you recommend this test for my situation?
• What evidence supports its use?
• How much does it cost?
• What are the risks?
• Could it change my treatment plan?

Making an Informed Decision

Every fertility journey is unique. While PGT-A, ERA, and immune testing may be helpful for some individuals, they are not universally recommended for every IVF cycle. Decisions should be based on your medical history, fertility diagnosis, previous treatment outcomes, and discussions with an experienced reproductive specialist.

The goal is not simply to add more testing, but to choose interventions that are supported by evidence and appropriate for your personal circumstances.

Conclusion

IVF add-ons continue to evolve as fertility research advances. Understanding what PGT-A, ERA, and immune testing can—and cannot—do allows patients to make informed choices about their treatment. Working closely with a knowledgeable fertility team ensures that every decision aligns with your medical needs, family-building goals, and available scientific evidence.

Frequently Asked Questions

Q. What is PGT-A in IVF?

Ans. PGT-A is a genetic test performed on IVF embryos to check for chromosomal abnormalities before embryo transfer, helping identify embryos with the correct number of chromosomes.

Q. Is ERA recommended for every IVF patient?

Ans. No. ERA is generally not recommended routinely. It may be considered for patients with repeated implantation failure after evaluation by a fertility specialist.

Q. Does immune testing improve IVF success rates?

Ans. Current evidence does not support routine immune testing or immune therapies for most IVF patients without diagnosed immune-related medical conditions.

Q. Are IVF add-ons covered by insurance?

Ans. Coverage varies by insurance provider, treatment plan, and location. Many IVF add-ons are considered optional and may require out-of-pocket payment.

Start your journey today. Contact Surrogacy4All at (212) 661-7673 or email info@surrogacy4all.com